Penn Capital Management Company, LLC
Position in ARQT — Arcutis Biotherapeutics, Inc.
CIK 1158202
PHILADELPHIA, PA
Position in ARQT
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$7,848,542
New position
Shares Held
333,130
first reported quarter
Ownership
0.265%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Penn Capital Management Company, LLC holds $100,162,194 across 7 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
298,914 | $34,993,861 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
100,337 | $31,715,522 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
536,067 | $29,451,520 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,811 | $1,509,366 | |
| 5 | TVTX |
Travere Therapeutics, Inc.
|
14,968 | $850,332 | |
| 6 | PVLA |
Palvella Therapeutics, Inc.
|
5,506 | $841,426 | |
| 7 | NRIX |
Nurix Therapeutics, Inc.
|
32,983 | $800,167 |
All Filings in ARQT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,848,542 | 333,130 | Shares | Sole | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||